Keenova Therapeutics plc Interest Payable, Current
Keenova Therapeutics plc had Interest Payable, Current of $18.00 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2026-08-11
- 2026-06-30: Interest Payable, Current $18.00M.
- 2026-03-31: Interest Payable, Current $39.30M.
- 2025-12-31: Interest Payable, Current $18.00M.
- 2025-09-26: Interest Payable, Current $61.30M.
| Period end | Interest Payable, Current |
|---|---|
| 2026-06-30 | $18.00M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $39.30M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $18.00M 10-Q · filed 2026-08-11 |
| 2025-09-26 | $61.30M 10-Q · filed 2025-11-10 |
| 2025-06-27 | $13.70M 10-Q · filed 2025-08-06 |
| 2025-03-28 | $26.90M 10-Q · filed 2025-05-12 |
| 2024-12-27 | $9.20M 10-K · filed 2026-04-15 |
| 2024-09-27 | $45.00M 10-Q · filed 2024-11-05 |
| 2024-06-28 | $17.10M 10-Q · filed 2024-08-06 |
| 2024-03-29 | $47.30M 10-Q · filed 2024-05-09 |
| 2023-12-29 | $20.10M 10-K · filed 2025-03-13 |
| 2023-09-29 | $34.60M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $81.00M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $76.80M 10-Q · filed 2023-05-09 |
| 2022-12-30 | $29.00M 10-K · filed 2024-03-26 |
| 2022-09-30 | $71.10M 10-Q · filed 2022-11-08 |
| 2022-07-01 | $21.20M 10-Q · filed 2022-08-11 |
| 2022-04-01 | $17.40M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $17.00M 10-K · filed 2023-03-03 |
| 2021-09-24 | $25.70M 10-Q · filed 2021-11-02 |
| 2021-06-25 | $27.70M 10-Q · filed 2021-08-03 |
| 2021-03-26 | $27.80M 10-Q · filed 2021-05-04 |
| 2020-12-25 | $26.90M 10-K · filed 2022-03-15 |
| 2020-09-25 | $89.10M 10-Q · filed 2020-11-03 |
| 2020-06-26 | $67.20M 10-Q · filed 2020-08-04 |
| 2020-03-27 | $82.30M 10-Q · filed 2020-05-06 |
| 2019-12-27 | $62.90M 10-K · filed 2021-03-10 |
| 2019-09-27 | $90.90M 10-Q · filed 2019-11-05 |
| 2019-06-28 | $45.90M 10-Q · filed 2019-08-06 |
| 2019-03-29 | $72.40M 10-Q · filed 2019-05-07 |
| 2018-12-28 | $77.60M 10-K · filed 2020-02-26 |
| 2018-09-28 | $77.00M 10-Q · filed 2018-11-06 |
| 2018-06-29 | $60.40M 10-Q · filed 2018-08-07 |
| 2018-03-30 | $81.50M 10-Q · filed 2018-05-08 |
| 2017-12-29 | $57.00M 10-K · filed 2019-02-26 |
| 2017-09-29 | $78.10M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $54.10M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $80.80M 10-Q · filed 2017-05-08 |
| 2016-12-30 | $68.70M 10-K · filed 2018-02-27 |
| 2016-09-30 | $80.60M 10-QT · filed 2017-02-07 |
| 2016-06-24 | $69.90M 10-Q · filed 2016-08-02 |
| 2016-03-25 | $98.30M 10-Q · filed 2016-05-03 |
| 2015-12-25 | $72.70M 10-Q · filed 2016-02-02 |
| 2015-09-25 | $80.20M 10-Q · filed 2016-08-02 |